Your browser doesn't support javascript.
loading
Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus.
Ibrahim, Mahmoud; Davies, Melanie J; Ahmad, Ehtasham; Annabi, Firas A; Eckel, Robert H; Ba-Essa, Ebtesam M; El Sayed, Nuha Ali; Hess Fischl, Amy; Houeiss, Pamela; Iraqi, Hinde; Khochtali, Ines; Khunti, Kamlesh; Masood, Shabeen Naz; Mimouni-Zerguini, Safia; Shera, Samad; Tuomilehto, Jaakko; Umpierrez, Guillermo E.
Afiliação
  • Ibrahim M; EDC Center for Diabetes Education, McDonough, Georgia, USA mahmoud@arab-diabetes.com.
  • Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Ahmad E; Diabetes Research Centre, University of Leicester and Leicester General Hospital, Leicester, UK.
  • Annabi FA; Islamic Hospital Amman, Amman, Jordan.
  • Eckel RH; Division of Endocrinology, Metabolism & Diabetes Division of Cardiology, University of Colorado Denver Anschutz Medical Campus Official Bookstore, Denver, Colorado, USA.
  • Ba-Essa EM; Dammam Medical Complex, Dammam, Saudi Arabia.
  • El Sayed NA; Adult Diabetes, Joslin Diabetes Center, Boston, Massachusetts, USA.
  • Hess Fischl A; Section of Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago Medicine, Chicago, Illinois, USA.
  • Houeiss P; Division of Endocrinology, American University, Beirut, Lebanon.
  • Iraqi H; Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco.
  • Khochtali I; Department of Endocrinolgy and Internal Medicine, University of Tunisia, Monstair, Tunisia.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Masood SN; Obstetrics & Gynecology, ISRA Medical University, Karachi, Sindh, Pakistan.
  • Mimouni-Zerguini S; Pierre & Marie Curie Center, University of Algiers, Algiers, Algeria.
  • Shera S; Diabetic Association of Pakistan, Karachi, Pakistan.
  • Tuomilehto J; Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland.
  • Umpierrez GE; Dasman Diabetes Institute, Kuwait City, Kuwait.
Article em En | MEDLINE | ID: mdl-32366501
Fasting the Holy month of Ramadan constitutes one of the five pillars of the Muslim faith. Although there is some evidence that intermittent fasting during Ramadan may be of benefit in losing weight and cardiometabolic risk factors, there is no strong evidence these benefits apply to people with diabetes. The American Diabetes Association/European Association for the Study of Diabetes consensus recommendations emphasize the importance of patient factors and comorbidities when choosing diabetes medications including the presence of comorbidities, atherosclerotic cardiovascular disease, heart failure, chronic kidney disease, hypoglycemia risk, weight issues and costs. Structured education and pre-Ramadan counseing are key components to successful management of patients with diabetes. These should cover important aspects like glycemic targets, self-monitoring of blood glucose, diet, physical activity including Taraweeh prayers, medication and dose adjustment, side effects and when to break the fast. The decision cycle adapted for the specific situation of Ramadan provides an aid for such an assessment. Children with type 1 diabetes should strongly be advised not to fast due to the high risk of acute complications such as hypoglycemia and probably diabetic ketoacidosis (DKA), although there is very little evidence that DKA is increased in Ramadan. Pregnant women with diabetes or gestational diabetes should be advised to avoid fasting because of possible negative maternal and fetal outcomes. Hypoglycemia is a common concern during Ramadan fasting. To prevent hypoglycemic and hyperglycemic events, we recommend the adoption of diabetes self-management education and support principles. The use of the emerging technology and continuous glucose monitoring during Ramadan could help to recognize hypoglycemic and hyperglycemic complications related to omission and/or medication adjustment during fasting; however, the cost represents a significant barrier.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Hipoglicemia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Hipoglicemia Idioma: En Ano de publicação: 2020 Tipo de documento: Article